Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2

Journal of Clinical Investigation

Volumn 99, Issue 9, 1997, Pages 2254-2259

  Sheng, Hongmiao ^a   Shao, Jinyi ^a   Kirkland, Susan C ^d   Isakson, Peter ^c   Coffey, Robert J ^a,b   Morrow, Jason ^a   Beaucnamp, R Daniel ^a   DuBois, Raymond N ^a,b,e  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

chemoprevention; colon cancer; cyclooxygenase 2; nonsteroidal antiinflammatory drug

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030947525     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119400     Document Type: Article

References (45)

1. Giovannucci, E., E.B. Rimm, M.J. Stampfer, G.A. Colditz, A. Ascherio, and W.C. Willett. 1994. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 121:241-246.
2. Giovannucci, E., K.M. Egan, D.J. Hunter, M.J. Stampfer, G.A. Colditz, W.C. Willett, and F.E. Speizer. 1995. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333:609-614.
3. Marnett, L.J. 1992. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52:5575-5589.
4. Thun, M.J., M.M. Namboodiri, and C.W.J. Heath. 1991. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325:1593-1596.
5. Thun, M.J., M.M. Namboodiri, E.E. Calle, W.D. Flanders, and C.W.J. Heath. 1993. Aspirin use and risk of fatal cancer. Cancer Res. 53:1322-1327.
6. Marnett, L.J. 1995. Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prev. Med. 24:103-106.
7. Meade, E.A., W.L. Smith, and D.L. DeWitt. 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268:6610-6614.
8. Laneuville, O., D.K. Breuer, D.L. Dewitt, T. Hla, C.D. Funk, and W.L. Smith. 1994. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 271:927-934.
9. O'Neill, G.P., J.A. Mancini, S. Kargman, J. Yergey, M. Y. Kwan, J.P. Falgueyret, M. Abramovitz, B.P. Kennedy, M. Ouellet, W. Cromlish, et al. 1994. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol. Pharmacol. 45:245-254.
10. Gierse, J.K., S.D. Hauser, D.P. Creely, C. Koboldt, S.H. Rangwala, P.C. Isakson, and K. Seibert. 1995. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J. 305:479-484.
11. Williams, C.W., and R.N. DuBois. 1996. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol. 270:G393-G400.
12. Nathans, D., L.F. Lau, B. Christy, S. Hartzell, Y. Nakabeppu, and K. Ryder. 1988. Genomic response to growth factors. Cold Spring Harbor Symp. Quant. Biol. 53:893-900.
13. Herschman, H.R. 1991. Primary response genes induced by growth factors and tumor promoters. Ann. Rev. Biochem. 60:281-319.
14. Masferrer, J.L., B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson, and K. Seibert. 1994. Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA. 91:3228-3232.
15. Eberhart, C.E., R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois. 1994. Dp-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1183-1188.
16. Kargman, S., G. O'Neill, P. Vickers, J. Evans, J. Mancini, and S. Jothy. 1995. Expression of prostaglandin G/H synthase-1 and -2 protein in human co-lon cancer. Cancer Res. 55:2556-2559.
17. Sano, H., Y. Kawahito, R.L. Wilder, A. Hashiramoto, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo, and T. Hla. 1995. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:3785-3789.
18. DuBois, R.N., A. Radhika, B.S. Reddy, and A.J. Entingh. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonie tumors. Gastroenterology. 110:1259-1262.
19. Williams, C.W., C. Luongo, A. Radhika, T. Zhang, L.W. Lamps, L.B. Nanney, R.D. Beauchamp, and R.N. DuBois. 1996. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology. 111:1134-1140.
20. Reddy, B.S., C.V. Rao, and K. Seibert. 1996. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56:4566-4569.
21. Prescott, S.M., and R.L. White. 1996. Self promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell. 87:783-786.
22. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell. 87:803-809.
23. Lampert, I.A., S. Kirkland, S. Farrell, and L.K. Borysiewicz. 1985. HLA-DR expression in a human colonie carcinoma cell line. J. Pathol. 146:337-344.
24. Brattain, M.G., W.D. Fine, F.M. Khaled, J. Thompson, and D.E. Brattain. 1981. Heterogeneity of malignant cells from a human colonie carcinoma. Cancer Res. 41:1751-1756.
25. Kirkland, S.C. 1985. Dome formation by a human colonie adenocarcinoma cell line (HCA-7). Cancer Res. 45:3790-3795.
26. Kirkland, S.C., K. Henderson, D. Liu, and M. Pignatelli. 1995. Organisation and gel contraction by human colonie carcinoma (HCA-7) sublines grown in 3-dimensional collagen gel. Int. J. Cancer. 60:877-882.
27. 2+ interactions affecting epithelial chloride secretion in human cultured colonie epithelia. Br. J. Pharmacol. 108:462-468.
28. Henderson, R.M., M.L. Ashford, L.J. MacVinish, and A.W. Cuthbert. 1992. Chloride channels and anion fluxes in a human colonic epithelium (HCA-7). Br. J. Pharmacol. 106:109-114.
29. Marsh, K.A., G.W. Stamp, and S.C. Kirkland. 1993. Isolation and characterization of multiple cell types from a single human colonic carcinoma: tumorigenicity of these cell types in a xenograft system. J. Pathol. 170:441-450.
30. Coffey, R.J., C.J. Hawkey, L. Damstrup, R. Graves-Deal, V.C. Daniel, P.J. Dempsey, R.N. DuBois, T. Jetton, and J. Morrow. 1997. EGF receptor activation induces nuclear targeting of COX-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells. Proc. Natl. Acad. Sci USA. 94:657-662.
31. Papadopoulos, N., N.C. Nicolaides, Y.F. Wei, S.M. Ruben, K.C. Carter, C.A. Rosen, W.A. Haseltine, R.D. Fleischmann, C.M. Fraser, M.D. Adams, et al. 1994. Mutation of a mutL homolog in hereditary colon cancer. Science (Wash. DC). 263:1559-1560.
32. Koi, M., A. Umar, D.P. Chauhan, S.P. Cherian, J.M. Carethers, T.A. Kunkel, and C.R. Boland. 1994. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 54:4308-4312.
33. Ramesh, G., and A.E. Levine. 1995. Pro-transforming growth factor-alpha processing in human colon carcinoma cells: role of protein kinase C. Int. J. Cancer. 62:492-497.
34. Levine, A.E. 1994. Involvement of protein kinase C and an elastase-like enzyme in the processing of transforming growth factor-alpha in human colon carcinoma cell lines. Int. J. Cancer. 58:129-134.
35. Groden, J., G. Joslyn, W. Samowitz, D. Jones, N. Bhattacharyya, L. Spirio, A. Thliveris, M. Robertson, S. Egan, M. Meuth, and R. White. 1996. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res. 55:1531-1539.
36. DuBois, R.N., J. Awad, J. Morrow, L.J. Roberts, and P.R. Bishop. 1994. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin, Invest. 93:493-498.
37. 1 delay in intestinal epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res. 56:733-737.
38. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
39. Wang, J., L. Sun, L. Myeroff, X. Wang, L.E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, J.K. Willson, and M.G. Brattain. 1995. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem. 270:22044-22049.
40. Kutchera, W., D.A. Jones, N. Matsunami, J. Groden, T.M. McInlyre, G.A. Zimmerman, R.L. White, and S.M. Prescott. 1996. Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA. 93:4816-4820.
41. Tsujii, M., and R.N. DuBois. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell. 83:493-501.
42. Beazer-Barclay, Y., D.B. Levy, A.R. Moser, W.F. Dove, S.R. Hamilton, B. Vogelstein, and K.W. Kinzler. 1996. Sulindac suppresses tumorigenesis in the min mouse. Carcinogenesis. 17:1757-1760.
43. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56:710-714.
44. Boolbol, S.K., A.J. Dannenberg, A. Chadburn, C. Martucci, X.J. Guo, J.T. Ramonetti, M. Abreu-Goris, H.L. Newmark, M.L. Lipkin, J.J. DeCossc, and M.M. Bertagnolli. 1996. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56:2556-2560.
45. Piazza, G.A., A.L. Rahm, M. Krutzsch, G. Sperl, N.S. Paranka, P.H. Gross, K. Brendel, R.W. Burt, D.S. Alberts, R. Pamukcu, and D.J. Ahnen. 1995. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55:3110-3116.